SEC Filing Details
Document Details
Form
Filing Date
Nov 17, 2026
Document Date
Nov 14, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Lexeo Therapeutics
Issuer
LEXEO THERAPEUTICS, INC.
Filer
Schilke Tobin
Contact Us
-
Investor Inquiries
-
Media Inquiries